Ella-Louise Handley

Ella-Louise Handley

Auto-generated profile, based on publicly available information

Ella-Louise Handley

University of Edinburgh

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
MHMaria Heim
Maria Heim
EHElla‐Louise Handley
Ella‐Louise Handley
DGDaniel Grant
Daniel Grant
LHLizi M. Hegarty
Lizi M. Hegarty
EEElaine Emmerson
Elaine Emmerson
ACAnthony Callanan
Anthony Callanan
Radiation‐induced hypothyroidism (RIHT) is a frequent consequence of head and neck radiotherapy, driven by oxidative stress, inflammation, and immune dysregulation. Current therapies address hormonal imbalance but not underlying tissue damage. Strategies involving macrophage modulation and oxidative stress reduction represent a promising target for restoring homeostasis in the irradiated thyroid. Electrospun polycaprolactone (PCL) scaffolds incorporating 0.5%–3% adenosine are developed to provide localized modulation of oxidative and inflammatory responses. Adenosine incorporation does not alter scaffold morphology or stability. In vitro studies demonstrate that 1% adenosine scaffolds enhance thyrocyte proliferation, epithelial cohesion, and expression of antioxidant enzymes glutathione peroxidase ( GPX1 ) and catalase ( CAT ), while reducing markers of senescence and apoptosis ( RGN , CDKN2A , CASP3 ). In parallel, adenosine scaffolds regulate THP‐1‐derived macrophage behaviour, promoting a pro‐reparative CD206+/CD163+ phenotype and reducing CD86, CD80 , and TNF α expression associated with inflammatory activation. This study identifies fibrosis and oxidative stress as contributors to RIHT and demonstrates the feasibility of adenosine‐blended scaffolds as a platform for targeting these mechanisms. Macrophage heterogeneity was characterized in the thyroid pre‐ and post‐irradiation for an immune‐guided design. The resulting scaffolds provide a targeted strategy to modulate key contributors to RIHT pathology, laying the groundwork for future in vivo validation.

12 August 2026 in Biofabrication
Verified
Journal Article
Open access
PDF file
MHMaria Heim
Maria Heim
EHElla-Louise Handley
Ella-Louise Handley
YGYunxi Gao
Yunxi Gao
AMAimee Mandel
Aimee Mandel
EEElaine Emmerson
Elaine Emmerson
ACAnthony Callanan
Anthony Callanan
Loss of functional thyrocytes following thyroid injury or radiotherapy remains a significant clinical challenge, motivating development of biomaterial-based strategies to support thyroid cell survival and function. 17 β -Estradiol (E2) has been shown to promote thyrocyte proliferation and antioxidant responses, although systemic or bolus delivery may induce cytotoxicity and raises concerns regarding long-term pathological effects. Here, electrospun polycaprolactone (PCL) scaffolds incorporating varying concentrations of E2 were developed as a localised hormone delivery platform for thyroid epithelial cells. E2 incorporation altered scaffold mechanical behaviour, hydrophilicity, and porosity in a concentration-dependent manner while preserving fibre morphology, crystallinity, and thermal stability. Scaffold-mediated E2 delivery supported sustained thyrocyte viability and proliferation compared with bolus E2 exposure, with intermediate E2 concentrations producing the most favourable biological response. Morphological analysis demonstrated extensive cell spreading and organised cytoskeletal structures without features associated with apoptosis. Although E2-loaded scaffolds did not exhibit direct radical scavenging activity, they promoted upregulation of antioxidant-associated genes, indicating indirect modulation of cellular redox homeostasis. Thyroid-specific functional markers associated with hormone synthesis and maintenance of the differentiated thyroid phenotype were largely preserved across scaffold groups during the 14 d culture period. Furthermore, no detectable BRAF V600E or V600K mutations were identified under any condition tested. Collectively, these findings demonstrate that electrospun E2@PCL scaffolds provide a tunable microenvironment capable of supporting thyrocyte survival, proliferation, and functional maintenance, highlighting their potential for thyroid tissue engineering applications targeting radiation-induced thyroid injury.